{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:40Z","timestamp":1786984300441,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.amjmed.2006.08.006","type":"journal-article","created":{"date-parts":[[2006,9,23]],"date-time":"2006-09-23T07:29:02Z","timestamp":1158996542000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"S1","title":["The Impact of Severe Exacerbations on Quality of Life and the Clinical Course of Chronic Obstructive Pulmonary Disease"],"prefix":"10.1016","volume":"119","author":[{"given":"Dennis E.","family":"Niewoehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2006.08.006_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","article-title":"Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease","volume":"340","author":"Niewoehner","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1183\/09031936.03.00013303","article-title":"Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations","volume":"21","author":"Jones","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.08.006_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1183\/09031936.05.00136304","article-title":"Physiological changes during symptom recovery from moderate exacerbations of COPD","volume":"26","author":"Parker","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.08.006_bib5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","article-title":"Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial","volume":"354","author":"Davies","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2006.08.006_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.08.006_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0149-2918(02)85139-6","article-title":"A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes","volume":"24","author":"Wilson","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2006.08.006_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/thorax.58.7.589","article-title":"Time course of recovery of health status following an infective exacerbation of chronic bronchitis","volume":"58","author":"Spencer","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2006.08.006_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2006.08.006_bib11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.04.00121404","article-title":"Impact of preventing exacerbations on deterioration of health status in COPD","volume":"23","author":"Spencer","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.08.006_bib12","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/rmed.2001.1208","article-title":"Quality of life in acute exacerbation of chronic bronchitis: results from a German population study","volume":"96","author":"Doll","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/thx.52.1.67","article-title":"Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease","volume":"52","author":"Osman","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2006.08.006_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1378\/chest.122.2.429","article-title":"Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases","volume":"122","author":"Fan","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.08.006_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/ajrccm.164.3.2010017","article-title":"Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health Study","volume":"164","author":"Kanner","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2006.08.006_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1378\/chest.119.2.344","article-title":"The costs of treating COPD in the United States","volume":"119","author":"Strassels","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.08.006_bib19","year":"2006","journal-title":"Web site of the Agency for Healthcare Research and Quality, US Dept of Health and Human Services"},{"key":"10.1016\/j.amjmed.2006.08.006_bib20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.118.5.1278","article-title":"Pharmacoeconomic evaluation of COPD","volume":"118","author":"Hilleman","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.08.006_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1164\/ajrccm.164.4.2009033","article-title":"Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease","volume":"164","author":"Sin","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1164\/ajrccm.154.4.8887592","article-title":"Outcomes following acute exacerbation of severe chronic obstructive lung disease","volume":"154","author":"Connors","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib23","series-title":"Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD)","author":"Wilt","year":"2005"},{"key":"10.1016\/j.amjmed.2006.08.006_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","article-title":"Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial","volume":"143","author":"Niewoehner","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2006.08.006_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002876.pub2","article-title":"Inhaled tiotropium for stable chronic obstructive pulmonary disease","author":"Barr","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2006.08.006_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","article-title":"Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD","volume":"26","author":"van Noord","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.08.006_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.rmed.2004.05.003","article-title":"The functional impact of adding salmeterol and tiotropium in patients with stable COPD","volume":"98","author":"Cazzola","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib29","series-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease\u2014Updated 2004","year":"2005"},{"key":"10.1016\/j.amjmed.2006.08.006_bib30","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(61)91248-X","article-title":"Prophylactic use of influenza vaccine in patients with chronic bronchitis: a pilot trial","volume":"2","author":"Howells","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2006.08.006_bib31","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1378\/chest.125.6.2011","article-title":"Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study","volume":"125","author":"Wongsurakiat","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2006.08.006_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-130-5-199903020-00003","article-title":"Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease","volume":"130","author":"Nichol","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib33","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/archinte.159.20.2437","article-title":"The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease","volume":"159","author":"Nichol","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib34","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1081\/COPD-200050674","article-title":"OM-85 BV, an immunomodulatory agent, for the prevention of exacerbations in chronic obstructive pulmonary disease: a systematic review of efficacy and safety","volume":"2","author":"Sprenkle","year":"2005","journal-title":"J Chron Obstruct Pulm Dis"},{"key":"10.1016\/j.amjmed.2006.08.006_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.38512.664167.8F","article-title":"Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence","volume":"331","author":"Taylor","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2006.08.006_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.163.5.585","article-title":"Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention","volume":"163","author":"Bourbeau","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib38","article-title":"Prophylactic antibiotic therapy for chronic bronchitis","author":"Black","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2006.08.006_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001287","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","volume":"2","author":"Poole","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2006.08.006_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast\u2014an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2006.08.006_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1183\/09031936.02.00284202","article-title":"Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?","volume":"20","author":"Ringbaek","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2006.08.006_bib42","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.200204-318OC","article-title":"Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial","volume":"167","author":"Ries","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib43","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.164.6.2006012","article-title":"Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation: EFRAM study","volume":"164","author":"Garcia-Aymerich","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2006.08.006_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000067462","article-title":"Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis","volume":"67","author":"Miravitlles","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.amjmed.2006.08.006_bib45","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/thorax.57.11.967","article-title":"Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study","volume":"57","author":"Godtfredsen","year":"2002","journal-title":"Thorax"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934306009272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934306009272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:43:12Z","timestamp":1757580192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934306009272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0002934306009272"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.08.006","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Severe Exacerbations on Quality of Life and the Clinical Course of Chronic Obstructive Pulmonary Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}